Investor Patience John
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Patience John . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-04-09 13D/A BDSX / Biodesix, Inc. 7,536,698 7,659,411
2023-08-07 13D/A BDSX / Biodesix, Inc. 7,153,297 7,536,698
2022-12-01 13D BDSX / Biodesix, Inc. 5,012,953 7,153,297
2022-01-10 13G/A BDSX / Biodesix, Inc. 5,012,953
2022-01-10 13G BDSX / Biodesix, Inc. 4,816,680
2018-02-09 13G/A US64052L1061 / Neos Therapeutics, Inc. 889,500 1,145,000
2017-02-09 13G/A US64052L1061 / Neos Therapeutics, Inc. 827,371 889,500
2016-09-14 13G US64052L1061 / Neos Therapeutics, Inc. 827,371
2016-02-25 13D/A AXDX / Accelerate Diagnostics, Inc. 6,500,070 6,551,346
2015-12-29 13D/A AXDX / Accelerate Diagnostics, Inc. 6,500,070
2013-09-03 13D/A AXDX / Accelerate Diagnostics, Inc. 6,157,340
2013-03-20 13D/A AXDX / Accelerate Diagnostics, Inc. 5,733,788